UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030348
Receipt number R000034554
Scientific Title Study for apoptosis inhibitor of macrophage (Free AIM) for the prediction of hepatocellular carcinoma.
Date of disclosure of the study information 2017/12/11
Last modified on 2022/06/15 14:40:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for apoptosis inhibitor of macrophage (Free AIM) for the prediction of hepatocellular carcinoma.

Acronym

Diagnostic performance of Free AIM for HCC

Scientific Title

Study for apoptosis inhibitor of macrophage (Free AIM) for the prediction of hepatocellular carcinoma.

Scientific Title:Acronym

Diagnostic performance of Free AIM for HCC

Region

Japan


Condition

Condition

Hepatocellular carcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate predictive performance of Free AIM for hepatocellular carcinoma

Basic objectives2

Others

Basic objectives -Others

utility

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate the efficacy of plasma concentration of Free AIM for hepatocellular carcinoma

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with chronic hepatitis/cirrhosis/hepatocellular carcinoma who have given written informed consent for preservation of serum sample for research purpose

Key exclusion criteria

none

Target sample size

1600


Research contact person

Name of lead principal investigator

1st name Ryosuke
Middle name none
Last name Tateishi

Organization

The University of Tokyo

Division name

Department of Gastroenterology

Zip code

113-8655

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

TEL

0338155411

Email

masayasato0407@gmail.com


Public contact

Name of contact person

1st name Sato
Middle name none
Last name Masaya

Organization

The University of Tokyo

Division name

Department of Clinical Laboratory Medicine

Zip code

113-8655

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

TEL

0338155411

Homepage URL


Email

masayasato0407@gmail.com


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Sekisui medical CO., LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Sekisui medical CO., LTD

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The University of Tokyo Hospital

Address

7-3-1, Hongo, Bunkyo ku

Tel

03-3815-5411

Email

CReSjimu-tokyo@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

74

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 24 Day

Date of IRB

2017 Year 10 Month 10 Day

Anticipated trial start date

2017 Year 12 Month 11 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Website for opt-out statement


Management information

Registered date

2017 Year 12 Month 11 Day

Last modified on

2022 Year 06 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034554


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name